Bioventus Inc Cl A (BVS)

Jan 2, 2025, 8:00 AM EST - 15 days ago

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

Nov 5, 2024, 12:26 PM EST - 2 months ago

Bioventus Inc. (BVS) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 7:30 AM EST - 2 months ago

Bioventus Reports Third Quarter Financial Results

Oct 29, 2024, 7:30 AM EDT - 2 months ago

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

Aug 21, 2024, 7:37 AM EDT - 5 months ago

Executives Buying W. P. Carey And 2 Other Stocks

WPC GWRS

Aug 12, 2024, 11:01 AM EDT - 5 months ago

Healing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024

Aug 11, 2024, 1:45 PM EDT - 5 months ago

Bioventus Inc. (BVS) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 4:15 PM EDT - 5 months ago

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

Aug 6, 2024, 7:30 AM EDT - 5 months ago

Bioventus Reports Second Quarter Financial Results

Jul 30, 2024, 7:30 AM EDT - 6 months ago

Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024

May 7, 2024, 12:02 PM EDT - 9 months ago

Bioventus, Inc. (BVS) Q1 2024 Earnings Call Transcript

May 7, 2024, 7:00 AM EDT - 9 months ago

Bioventus Reports First Quarter Financial Results

Apr 29, 2024, 7:30 AM EDT - 9 months ago

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

Mar 12, 2024, 11:00 AM EDT - 11 months ago

Bioventus Inc. (BVS) Q4 2023 Earnings Call Transcript

Mar 12, 2024, 7:30 AM EDT - 11 months ago

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

Mar 4, 2024, 8:00 AM EST - 11 months ago

Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024

Jan 24, 2024, 2:00 PM EST - 1 year ago

Bioventus: Bullish On Path To Profitability

Jan 18, 2024, 4:15 PM EST - 1 year ago

Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility

Jan 12, 2024, 4:15 PM EST - 1 year ago

Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole

Dec 19, 2023, 4:30 PM EST - 1 year ago

Bioventus Names Robert Claypoole as President and Chief Executive Officer

Dec 6, 2023, 8:00 AM EST - 1 year ago

Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

Nov 12, 2023, 12:55 AM EST - 1 year ago

Bioventus Inc. (BVS) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 7:00 AM EST - 1 year ago

Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance

Oct 31, 2023, 7:00 AM EDT - 1 year ago

Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023

Oct 11, 2023, 5:44 PM EDT - 1 year ago

Bioventus Stock: Improving Outlook Keeps It Interesting

Sep 19, 2023, 9:52 PM EDT - 1 year ago

Bioventus to Present at the Cantor Global Healthcare Conference

Sep 6, 2023, 4:30 PM EDT - 1 year ago

Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

Aug 12, 2023, 1:56 PM EDT - 1 year ago

Bioventus Inc. (BVS) Q2 2023 Earnings Call Transcript

Aug 8, 2023, 7:30 AM EDT - 1 year ago

Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance

Aug 4, 2023, 8:30 AM EDT - 1 year ago

Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference

Aug 1, 2023, 5:35 PM EDT - 1 year ago

Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023

Jun 28, 2023, 2:18 PM EDT - 1 year ago

Bioventus: Return Of The King

May 23, 2023, 7:30 AM EDT - 1 year ago

Bioventus Completes Divestiture of its Wound Business

May 16, 2023, 10:53 PM EDT - 1 year ago

Bioventus Inc. (BVS) Q1 2023 Earnings Call Transcript

May 15, 2023, 5:33 PM EDT - 1 year ago

Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023

May 11, 2023, 7:00 AM EDT - 1 year ago

Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023

May 10, 2023, 9:00 AM EDT - 1 year ago

Bioventus Announces Divestiture of its Wound Business

May 3, 2023, 8:30 AM EDT - 1 year ago

Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023

Apr 5, 2023, 8:00 AM EDT - 1 year ago

Bioventus Announces CEO Leadership Change

Mar 31, 2023, 2:56 PM EDT - 1 year ago

Bioventus Inc. (BVS) Q4 2022 Earnings Call Transcript

Mar 31, 2023, 7:30 AM EDT - 1 year ago

Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results

Mar 29, 2023, 8:55 AM EDT - 1 year ago

Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023

Mar 16, 2023, 8:30 AM EDT - 2 years ago

Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023

Mar 12, 2023, 8:50 PM EDT - 2 years ago

INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Bioventus Inc. with Losses of $100,000 to Contact the Firm

Mar 11, 2023, 7:00 AM EST - 2 years ago

BIOVENTUS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Bioventus To Contact Him Directly To Discuss Their Options

Feb 28, 2023, 9:20 AM EST - 2 years ago

Deadline in Lawsuit for Investors who Lost over $100,000 in shares of Bioventus Inc. between February 2021 and November 2022 announced by Shareholders Foundation

Feb 28, 2023, 7:30 AM EST - 2 years ago

Bioventus Enters into Settlement Agreement to Preserve Maximum Optionality – Up To $350mm of Potential Liability Reduction and a Release of Future Claims related to the CartiHeal Acquisition

Feb 16, 2023, 8:25 PM EST - 2 years ago

Bioventus Shareholder Action Reminder

Feb 7, 2023, 10:54 AM EST - 2 years ago

Bioventus Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information